PANews reported on October 14th that according to PR Newswire, TAO Synergies Inc. (Nasdaq: TAOX), a TAO treasury company, announced that it has signed a securities subscription agreement with existing investor James Altucher and new investor DCG, securing $11 million in financing. The financing, completed through a private placement at a premium to the company's five-day moving average, involved the sale of 11,000 shares of the company's newly issued Series E convertible preferred stock, par value $1,000 per share, convertible into the company's common stock, along with five-year common stock purchase warrants. The Series E preferred stock has a conversion price of $8.00 per share, and the warrants have an exercise price of $8.00 per share. The transaction is expected to close on or about October 15, 2025, subject to customary closing conditions.PANews reported on October 14th that according to PR Newswire, TAO Synergies Inc. (Nasdaq: TAOX), a TAO treasury company, announced that it has signed a securities subscription agreement with existing investor James Altucher and new investor DCG, securing $11 million in financing. The financing, completed through a private placement at a premium to the company's five-day moving average, involved the sale of 11,000 shares of the company's newly issued Series E convertible preferred stock, par value $1,000 per share, convertible into the company's common stock, along with five-year common stock purchase warrants. The Series E preferred stock has a conversion price of $8.00 per share, and the warrants have an exercise price of $8.00 per share. The transaction is expected to close on or about October 15, 2025, subject to customary closing conditions.

TAO Finance, a US-listed company, secured $11 million in private placement financing.

2025/10/14 09:34

PANews reported on October 14th that according to PR Newswire, TAO Synergies Inc. (Nasdaq: TAOX), a TAO treasury company, announced that it has signed a securities subscription agreement with existing investor James Altucher and new investor DCG, securing $11 million in financing. The financing, completed through a private placement at a premium to the company's five-day moving average, involved the sale of 11,000 shares of the company's newly issued Series E convertible preferred stock, par value $1,000 per share, convertible into the company's common stock, along with five-year common stock purchase warrants. The Series E preferred stock has a conversion price of $8.00 per share, and the warrants have an exercise price of $8.00 per share. The transaction is expected to close on or about October 15, 2025, subject to customary closing conditions.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.